Medicare Coverage for Keytruda

If you or someone you love has been prescribed Keytruda, one of the first questions is usually not
“How does immunotherapy work?” (although that’s important). It’s more like: “Will Medicare cover this,
and how much is this going to cost me?”

Totally fair question. Keytruda (pembrolizumab) is a widely used cancer immunotherapy, and while Medicare
often covers it, the details can get a little… spreadsheet-y. The good news: once you understand which part
of Medicare pays for what, the whole thing becomes much less mysterious.

In this guide, we’ll break down how Medicare coverage for Keytruda usually works, what costs to expect,
where Medicare Advantage and Medigap fit in, and what to do if coverage is delayed or denied. We’ll also add
real-world-style experiences at the end, because sometimes the best explanation is seeing how it plays out for
actual families.

What Is Keytruda and Why Medicare Coverage Questions Are So Common?

Keytruda is the brand name for pembrolizumab, a prescription immunotherapy drug. It’s a
PD-1 checkpoint inhibitor, which means it helps the immune system recognize and attack cancer cells more
effectively. In plain English: it helps take the “brakes” off certain immune responses so your body can better
fight cancer.

It’s used for many different cancer types and treatment settings, which is part of why coverage questions
come up so often. It may be used alone or combined with chemotherapy or other medications, depending on the
cancer type, stage, biomarker results, and treatment plan.

Another key detail: Keytruda is commonly given as an intravenous (IV) infusion in a clinic
or hospital outpatient setting. That matters because Medicare coverage is often based on how a drug is
administered, not just what the drug is.

Does Medicare Cover Keytruda?

Usually, yesMedicare often covers Keytruda when it is medically necessary and prescribed for an
appropriate cancer treatment use. But the type of Medicare you have (Original Medicare vs. Medicare
Advantage) affects how the claim is processed and what you pay out of pocket.

Original Medicare (Part A and Part B)

In most cases, Keytruda falls under Medicare Part B because it’s typically administered by
infusion in a doctor’s office, infusion center, or hospital outpatient department. Medicare Part B generally
covers many chemotherapy and similar outpatient cancer drugs that are given through a vein, along with the
administration service itself.

If you receive cancer treatment while admitted as a hospital inpatient, coverage may instead involve
Part A for the inpatient stay and related services. This is less about the drug itself and
more about the setting where care is delivered.

Medicare Advantage (Part C)

Medicare Advantage plans must cover at least everything Original Medicare covers, but they often add plan
rules like:

• Prior authorization requirements
• Network restrictions (which hospitals/oncologists are in-network)
• Different copays or coinsurance structures
• Referral requirements in some plan types

So yes, a Medicare Advantage plan may cover Keytrudabut you may need extra paperwork before the first
infusion. Think of it as the “yes, but please complete these 14 forms first” version of coverage.

What About Medicare Part D?

Usually not for standard IV Keytruda infusions. Part D generally covers self-administered
outpatient prescription drugs filled at a pharmacy. Since Keytruda is commonly infused in a clinical setting,
it is usually a Part B drug, not a Part D drug.

That said, Part D can still matter a lot during cancer treatment because it may cover supportive medications
(anti-nausea meds, pain meds, some oral therapies, etc.). So even if Keytruda itself is billed to Part B,
your overall cancer costs may involve both Part B and Part D.

When Medicare Covers Keytrudaand When It Might Not

Medicare coverage is not just “drug name = approved.” It generally depends on whether the treatment is:

• Medically necessary
• Ordered and administered by an eligible provider
• Used in a covered setting
• Properly documented and billed
• Supported by the diagnosis and treatment plan

Keytruda has many FDA-approved indications, and oncologists also rely on testing (such as PD-L1 or other
biomarker results) to determine whether it fits the clinical situation. If documentation is incomplete, if a
plan requires prior authorization that wasn’t obtained, or if coding details are off, a claim can be delayed
or denied even when the treatment itself is appropriate.

This is why your oncology office’s billing team is your secret weapon. They deal with these claims every day
and usually know exactly which forms, diagnosis codes, and records a plan wants.

How Much Does Keytruda Cost With Medicare?

This is the question everyone wants answered, and the honest answer is: it varies a lot.
Your out-of-pocket costs depend on your Medicare coverage type, whether you have supplemental insurance, where
you get treatment, and your plan’s cost-sharing rules.

If Keytruda Is Covered Under Part B

Under Original Medicare, Part B generally involves:

• A monthly Part B premium
• An annual Part B deductible
• Typically 20% coinsurance after the deductible for covered Part B services/drugs

That 20% coinsurance is the part that can feel scary with high-cost cancer drugs. Even when Medicare covers
the treatment, 20% of a big number is still a big number.

How Medigap Can Help

If you have Medigap (Medicare Supplement Insurance) with Original Medicare, it may help
cover some or all of your Part B coinsurance (depending on the plan type). For many people on expensive
outpatient treatment, Medigap is what turns “financial panic” into “okay, this is manageable.”

Medigap doesn’t replace Medicareit works alongside it. Medicare pays first, then Medigap may help with the
remaining approved costs.

If You Have Medicare Advantage

Medicare Advantage plans set their own cost-sharing (within Medicare rules), so costs can look different:

• A copay per infusion visit
• Coinsurance for outpatient hospital services
• Different costs depending on in-network vs. out-of-network care
• An annual out-of-pocket maximum for covered services (a major difference from Original Medicare)

Always check your Evidence of Coverage or call your plan before treatment starts. Ask specifically how
outpatient infusion immunotherapy is billed and what your cost-sharing will be.

Prior Authorization and Medicare Coverage Delays

Prior authorization is one of the biggest speed bumps in cancer care billingespecially in Medicare Advantage.
Original Medicare usually doesn’t require prior authorization for most routine covered services, but Medicare
Advantage plans often do.

A prior authorization request typically includes:

• Your diagnosis
• Pathology/biomarker results
• The treatment plan
• Why Keytruda is medically appropriate
• Requested treatment schedule and setting

If the plan asks for more documentation, it can delay the start date. Frustrating? Yes. Common? Also yes.
This is why it helps to ask your oncology team one simple question: “Has prior authorization been
approved yet?”

Bonus tip: ask for the authorization number and the date it was approved. It’s not glamorous, but it’s a very
useful number to have.

Financial Help Options If Medicare Still Leaves a Big Bill

Medicare coverage and affordability are not the same thing. You can have approved treatment and still struggle
with out-of-pocket costs. If that’s your situation, here are common places to look for help:

1) Medigap (for Original Medicare)

As mentioned, Medigap can reduce or cover Part B coinsurance for many people. If you’re newly eligible for
Medicare, compare Medigap options early.

2) Medicare Savings Programs (MSPs)

If you have limited income and resources, your state may help pay Medicare premiums and cost-sharing through a
Medicare Savings Program. This can be a huge help with Part A and Part B costs.

3) Extra Help (for Part D costs)

Extra Help is for Part D drug costs, not Part B infusion drugsbut it still matters because
cancer treatment often includes pharmacy medications. It can lower or eliminate Part D premiums, deductibles,
and copays for eligible people.

4) Manufacturer Support Programs

Merck offers support resources and a patient access program that may help eligible patients understand
coverage options and financial assistance pathways. Eligibility rules vary, and programs can change, so it’s
worth contacting them directly rather than guessing.

5) SHIP Counseling (Free Medicare Help)

SHIP (State Health Insurance Assistance Program) counselors provide free, unbiased Medicare counseling. If you
feel buried under acronyms and bills, SHIP is exactly the kind of “real human, plain English” help you want.

What to Do If Medicare or Your Plan Denies Keytruda Coverage

First: don’t panic. A denial does not always mean “never covered.” Sometimes it means:

• Missing documentation
• Incorrect coding
• Prior authorization issue
• Need for additional records
• Billing under the wrong setting or benefit category

Here’s the best next-step playbook:

1. Read the notice carefully. Look for the reason code or denial explanation.
2. Call your oncology billing office. Ask whether they can correct and resubmit.
3. Call Medicare or your Medicare Advantage plan. Confirm what documentation is missing.
4. Ask your doctor for supporting records. Clinical notes and test results often matter.
5. File an appeal. Medicare and Medicare plans have formal appeal processes.

Original Medicare has a multi-level appeal process, and Medicare drug/health plans also have structured appeal
steps. Keep copies of everything you send. Seriouslyeverything. A folder (digital or paper) can save your
future self from a lot of stress.

A Simple Checklist Before Starting Keytruda on Medicare

Here’s a practical checklist you can use before the first infusion:

• Confirm whether you have Original Medicare or Medicare Advantage
• Ask which part is billing the drug (usually Part B for IV infusion)
• Confirm your treatment location is in-network (if on Medicare Advantage)
• Ask whether prior authorization is required and approved
• Request an estimate of your out-of-pocket cost
• Check whether you have Medigap or other supplemental coverage
• Ask about financial counseling at the cancer center
• Explore Medicare Savings Programs / Extra Help if eligible
• Keep all notices, EOBs, and Medicare Summary Notices in one place

It may feel like a lot, but this checklist can prevent the two biggest headaches: delayed treatment and surprise
bills.

Final Thoughts on Medicare Coverage for Keytruda

In most cases, Medicare does cover Keytruda when it’s medically appropriate and properly
documentedespecially when it’s given as an outpatient IV infusion under Part B. The bigger issue is often not
whether it’s covered, but how much of the remaining cost you’ll owe and how smoothly the claim gets
processed.

The best strategy is a mix of planning and persistence: verify the billing path, confirm prior authorization
(if applicable), understand your coinsurance, and ask for help early from your oncology billing team, SHIP, or
Medicare. Cancer treatment is hard enough. Your insurance paperwork should not get to be the main character.

Experiences With Medicare Coverage for Keytruda

Note: The examples below are composite scenarios based on common Medicare coverage situations. They’re
written to help you understand how coverage issues can play out in real life, not to replace medical or legal
advice.

Experience 1: Original Medicare + Medigap = Fewer Surprises

A retired teacher in Ohio started Keytruda after a lung cancer diagnosis. Her oncologist’s office billed the
infusions under Part B, just as expected. She had Original Medicare plus a Medigap plan, and that ended up
being the financial game-changer. Medicare paid its share, and her Medigap plan covered most of the remaining
Part B cost-sharing. Her biggest challenge wasn’t the drug billit was transportation and scheduling.

Her takeaway: “I thought the medicine would be the biggest insurance problem, but my supplemental coverage
handled more than I expected. The clinic helped me understand the paperwork before the first infusion.”

Experience 2: Medicare Advantage and the Prior Authorization Bottleneck

A man in Texas with a Medicare Advantage PPO was approved for Keytruda, but the first infusion was delayed
because the plan requested additional records. His doctor had submitted the diagnosis and treatment plan, but
the insurer also wanted a pathology report and biomarker testing details. Once the oncology office sent the
extra documentation, the authorization came through.

He still had coinsurance for the outpatient infusion center, but the plan’s out-of-pocket maximum helped him
estimate the worst-case annual cost. His advice to others: “Don’t assume the doctor’s office and the plan are
synced. Call the plan yourself and ask if the authorization is approved.”

Experience 3: Dual Eligibility and Help With Costs

A patient in Florida had both Medicare and Medicaid. Keytruda was covered through the Medicare side as an
outpatient infusion drug, but Medicaid and low-income assistance significantly reduced what she had to pay.
Her cancer center connected her with a financial navigator who also reviewed her Part D coverage for supportive
medications. That made a huge difference because the anti-nausea and other pharmacy prescriptions added up
quickly.

Her family said the most helpful step was meeting the financial navigator before treatment started.
“We thought we had to figure it all out alone. We didn’t.”

Experience 4: A Denial That Was Really a Documentation Problem

One caregiver described getting a denial notice after the second Keytruda infusion and feeling totally blindsided.
After several calls, they learned the claim issue wasn’t the drug itselfit was a billing documentation mismatch.
The provider corrected the coding and resubmitted the claim, and the payment was processed.

Their biggest lesson: save every Medicare Summary Notice and every explanation from the plan. When they appealed,
they had dates, claim numbers, and the exact language from the notice. That made the process much easier (still
annoying, but easier).

Experience 5: Using SHIP for a Plan Review

Another family met with a SHIP counselor during open enrollment after a year of high cancer treatment bills.
They reviewed whether staying on Medicare Advantage made sense or whether Original Medicare plus Medigap would
be a better fit the next year. The counselor explained the tradeoffs clearly: provider networks, premiums,
coinsurance, and likely oncology costs.

They ended up switching coverage and felt more prepared the following year. The caregiver put it best:
“We didn’t need more internet opinions. We needed someone who knew Medicare and could explain it like a human.”

SEO Tags